News

Each treatment saw very mild clinical and dermatologic responses with low levels of patient satisfaction.

This review of the latest dermatologic studies includes insights into endocrine, psychological and nutritional aspects in women with hidradenitis suppurativa; forms of hair loss among individuals with anxiety disorder; and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Lisa Weiss, MMSc, PA-C, and colleagues offered insights on managing severe atopic dermatitis cases with biologics, nonsteroidal treatments, and strategies for addressing physical and emotional impacts.

Catch up on coverage from the 2025 South Beach Symposium held in Miami Beach, Florida.

Recent technological advancements such as the development and use of human cellular and tissue-based products and advanced skin substitutes have transformed limb preservation.

Dobkin underwent the procedure in order to connect with his patients considering it for themselves.

Botox Cosmetic has evolved from its accidental discovery to a leading treatment in dermatology, balancing medical innovation with ethical considerations.

A recent expert discussion highlighted the importance of long-term planning, including when and how to adjust or transition therapies.

The top videos under the hashtag, #spironolactone” had low scores on the mDISCERN and GQS scales, according to Adam Friedman, MD, FAAD, senior author of the study.

Review emerging therapies for vitiligo, melasma, PIH, and albinism, including topical, systemic, light-based, and laser treatments.

Tina Bhutani-Jacques, MD, highlighted the importance of individualized and informative care while building trust among patients and caregivers.

Explore the top headlines of the week including Allergan Aesthetics' new AA Signature program, the launch of EltaMD's new UV Skin Recovery broad spectrum SPF 50 face sunscreens, and more.

Lio emphasizes that patient comfort and understanding are essential for successful treatment outcomes.

Nektar Therapeutics’ investigational biologic targets the IL-2 receptor complex.

Many patients, especially parents of pediatric patients, exhibit steroid phobia, impacting treatment adherence.

Swanson shared strategies for treating rural dermatology patients at MOPD 2025, emphasizing effective initial care, the role of telehealth, and practical treatments.

Long-term safety data suggests that JAK inhibitors have a lower risk of cardiovascular and thromboembolic events than previously thought.

Medical and aesthetic dermatologists partner at SBS 2025 to bridge gaps between clinical care and cosmetic procedures.

Michael Gold, MD, explored microneedling innovations, pulse wave technology for pigmentation, and the aesthetic effects of GLP-1 receptor agonists, including "Ozempic face" and skin laxity.

Catch up on coverage from the third day of the 2025 South Beach Symposium held in Miami Beach, Florida.

Advances in biologics, JAK inhibitors, and PDE4 inhibitors provide personalized options for psoriasis management.

Compliance with acne medications remains a challenge, but timely intervention can prevent severe skin damage.

Mona Shahriari, MD, FAAD advocates for improving diversity in clinical imagery and trials to enhance trust in patients with skin of color.

Many patients with severe AD are unaware of newer, more effective treatments.

A holistic yet time-efficient approach can help dermatologists recognize early joint pain symptoms associated with psoriasis.

A balanced approach to dermatologic care involves using steroids for flare-ups and switching to non-steroidal options for maintenance.

Chilukuri said devices should be user-friendly even in solo practice settings to maximize efficiency and usability.

Catch up on coverage from the second day of the 2025 South Beach Symposium held in Miami Beach, Florida.

Michael Gold, MD, explored medical and procedural acne treatments and the emerging role of exosomes in regenerative dermatology.